An expert discusses treatment strategies for immune thrombocytopenic purpura (ITP), emphasizing individualized decisions based on platelet count, bleeding symptoms, and comorbidities, with options ...
An expert discusses how rilzabrutinib’s covalent reversible binding mechanism provides a favorable safety profile with only manageable grade 1 to 2 toxicities and no cardiovascular or bleeding ...
Immune thrombocytopenia (ITP) is a rare blood disorder in which the immune system mistakenly attacks and destroys platelets. Platelets are small blood cells that play a critical role in helping your ...
Hetrombopag has demonstrated high response rates along with a favourable safety profile in children suffering from immune thrombocytopenia (ITP), reinforcing its role as an effective second-line ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results